- Poster presentation
- Open Access
Myocardial late gadolinium enhancement in systemic lupus erythematosus as a marker of chronic inflammation
© Braggion Santos et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Systemic Lupus Erythematosus
- Cardiovascular Magnetic Resonance
- Systemic Lupus Erythematosus Patient
- Late Gadolinium Enhancement
- Cardiac Involvement
Cardiac involvement of patients with systemic lupus erythematosus (SLE) is one of the main complications contributing to morbidity and mortality, however a significant portion of patients presents with subclinical disease. Non-invasive contrast-enhanced cardiovascular magnetic resonance (CMR) imaging is a well-established diagnostic tool to identify myocardial tissue alterations and morphological and functional changes. In this study, we aimed to assess cardiac abnormalities in SLE patients using LGE-CMR and, furthermore, the relation of serological inflammatory biomarkers to the cardiac LGE-CMR findings.
We studied 27 SLE patients (24 females, 45 ± 13 years) and 30 healthy age-matched volunteers who served as a control group (27 females, 44 ± 11 years). Cine MRI with 32 channel image acquisition and vector-ECG gated short axis, two and four chamber cine slices with parallel image acquisition covering the entire left ventricle (LV) were acquired using a regular SSFP sequence on a 1.5T Whole Body MRI scanner (Achieva 1.5T, Philips Medical Systems). LGE-CMR (GadoliniumDTPA: 0.2 mmol/kg, Magnevist) was performed and analyzed by two blinded experienced observers. Analysis of the presence and distribution of LGE forms was compared to serum levels of anti-ds DNA, C- reactive protein as markers of disease activity and inflammation. Groups were compared using the Student's t-test or the Mann-Whitney test and Fisher's exact test. P-values ≤ 0.05 were considered statistically significant.
Clinical characteristics and disease features in SLE patients according to the presence or absence of myocardial involvement revealed on LGE images.
LGE positive (n = 19)
LGE negative (n = 8)
Clinical and laboratorial features
43.8 ± 12.4
48.9 ± 13.2
SLE duration, years
13.6 ± 5.1
15.2 ± 10.6
SLEDAI score (>4), no. (%)
Cardiovascular symptoms, no. (%)
Antiphospholipid syndrome, no. (%)
Anti-ds DNA antibodies (10 µl/l), no. (%)
CRP* (>2 mg/l), no.(%)
MDRD** (ml/min/1.73 m2)
81.1 ± 39.3
65.3 ± 27.7
Presence of myocardial LGE in SLE patients is a common finding and may be associated with a chronic and exacerbated inflammatory process. Taking into consideration the significant cardiovascular morbidity and mortality in SLE patients, and the difficulty in the early detection of cardiac manifestations, CMR could serve as a non-invasive diagnostic tool to assess cardiac SLE involvement and to aid in the cardiovascular risk stratification of these patients.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.